We submit herewith Statement of Deviation & Variation under Reg 32 of Sebi LODR 2015

August 05. 2026 BSE Limited National Stock Exchange of India Limited 25, P. J. Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra — Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai — 400 051 Scrip Code: 500120 Symbol: DIAMINESQ Sub: Disclosure of Regulation 32(1) of The SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Quarter ended on June 30, 2026 Dear Sir/Ma’am, Pursuant to the Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the statement of deviation or variation of fund raised through preferential issue under Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Quarter ended on June 30, 2026, is enclosed herewith. Kindly take the above mentioned information on records. Thanking You, Yours Faithfully, For Diamines and Chemicals Limited Hemaxi Pawar Company Secretary Membership No.: A52581 Encl: As above Diamines and Chemicals Limited (CIN No.L24110GJ1976PLC002905) Plot No. 13 P.C.C. Area, P.O. Petrochemicals, Dist. Vadodara 391346, Gujarat (India). T: +91 265 3534200, F: +91 265 2230218 E: info@dacl.co.in, W:dacl.co.in Statement of Deviation / Variation in utilisation of funds raised Name of listed entity Diamines And Chemicals Limited Mode of Fund Raising Public Issues / Rights Issues / Preferential Issues / QIP / Others Date of Raising Funds October 01, 2024 (Allotment of Warrants) & March 24, 2026 (Date of Allotment of Equity on conversion of Warrants) Amount Raised ` 50.58 Cr (100% of issue) * Report filed for Quarter ended June 30, 2026 Monitoring Agency applicable / not applicable Monitoring Agency Name, if NA applicable Is there a Deviation / Variation Yes / No in use of funds raised If yes, whether the same is NA pursuant to change in terms of a contract or objects, which was approved by the shareholders If Yes, Date of shareholder NA Approval Explanation for the Deviation / NA Variation Comments of the Audit None Committee after review Comments of the auditors, if None Objects for which funds have been raised and where there has been a deviation, in the following table Original Object Modified Original Modifi Funds Amount of Remarks Object, if Allocation ed Utilised Deviation/Var any (Rs in allocat (Rs in iation for the Crores) ion, if Crores) quarter any according to applicable object capital expenditures, working NA 12.51 Cr NA 12.51 Cr - Rs. 12.51 crores (i.e. capital requirements, acquisition, & & 25% of the issue i.e. investment in technology and for 11.15 Cr 11.15 Cr* 9,06,390 convertible general corporate purpose warrants @ Rs. 138 per warrant) and utilised for the quarter ended March 31, 2026 Rs. 11.15 crores (i.e. 75% of issue i.e. Rs. 414 per share) received and 2,69,402 equity shares allotted on 24.03.2026) and utilised for the quarter ended June 30, 2026 Diamines and Chemicals Limited (CIN No.L24110GJ1976PLC002905) Plot No. 13 P.C.C. Area, P.O. Petrochemicals, Dist. Vadodara 391346, Gujarat (India). T: +91 265 3534200, F: +91 265 2230218 E: info@dacl.co.in, W:dacl.co.in Deviation or variation means: (a) Deviation in the object or purposes for which the funds has been raised or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed or (c) Change in the terms of contract referred to in the funds raising documents i.e. prospectus, letter of offer, etc *Note: The Company had received In-Principle approval on September 19, 2024 for issue not exceeding 916390 number of convertible warrants at Rs. 552 per warrant. The Board, in its meeting held on October 01, 2024, had allotted 906390 convertible warrants on receipt of subscription money Rs. 12.51 crores i.e. 25% of the total Issue, on preferential basis to the investors. Further, out of total issued 906390 warrants, the Company had made allotment of 2,69,402 equity shares (conversion of warrants issued on preferential basis), on receipt of exercise money Rs. 11.15 crores (75% of the issue) by passing board resolution at duly convened board meeting on March 24, 2026, to the applicant from whom entire money has been received and rest all warrants were lapsed as at March 31, 2026 (Last date of conversion of warrants into Equity Shares). Entire Fund has been utilised as on June 30, 2026. Diamines and Chemicals Limited (CIN No.L24110GJ1976PLC002905) Plot No. 13 P.C.C. Area, P.O. Petrochemicals, Dist. Vadodara 391346, Gujarat (India). T: +91 265 3534200, F: +91 265 2230218 E: info@dacl.co.in, W:dacl.co.in